Visgeneer Inc. (TPEX:4197)
Taiwan · Delayed Price · Currency is TWD 9.02
-0.40 (-4.25%)
Mar 31, 2026, 11:34 AM CST
Visgeneer Market Cap
Visgeneer has a market cap or net worth of 272.23 million as of April 1, 2026. Its market cap has decreased by -16.48% in one year.
Market Cap
272.23M
Enterprise Value
306.27M
Revenue
159.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
9.02
Market Cap Chart
Since October 24, 2013, Visgeneer's market cap has decreased from 898.66M to 272.23M, a decrease of -69.71%. That is a compound annual growth rate of -9.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2026 | 272.23M | -7.01% |
| Dec 31, 2025 | 292.75M | -0.72% |
| Dec 31, 2024 | 294.87M | -8.69% |
| Dec 29, 2023 | 322.94M | 1.90% |
| Dec 30, 2022 | 316.90M | -17.97% |
| Dec 30, 2021 | 386.32M | -8.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NatureWise Biotech & Medicals | 935.35M |
| Taiwan Advance Bio-Pharmaceutical | 927.00M |
| Neith | 899.73M |
| TCI GENE | 895.62M |
| BioLASCO Taiwan | 737.63M |
| SynCore Biotechnology Co.,Ltd | 706.82M |
| TaiwanJ Pharmaceuticals | 602.52M |
| Vectorite Biomedical | 540.58M |